Considerably unfolded transthyretin monomers preceed and exchange with dynamically structured amyloid protofibrils

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Groenning, Minna ^a,b   Campos, Raul I ^b   Hirschberg, Daniel ^b   Hammarström, Per ^b   Vestergaard, Bente ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PREALBUMIN;

CHEMISTRY; CIRCULAR DICHROISM; DEUTERIUM HYDROGEN EXCHANGE; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; METABOLISM; PROTEIN TERTIARY STRUCTURE; PROTEIN UNFOLDING; SMALL ANGLE SCATTERING; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

AMYLOID; CIRCULAR DICHROISM; DEUTERIUM EXCHANGE MEASUREMENT; MASS SPECTROMETRY; MICROSCOPY, ELECTRON, TRANSMISSION; PREALBUMIN; PROTEIN STRUCTURE, TERTIARY; PROTEIN UNFOLDING; SCATTERING, SMALL ANGLE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84933054772     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11443     Document Type: Article

References (82)

1. Goodman, D. S. & Raz, A. Extraction and recombination studies of the interaction of retinol with human plasma retinol-binding protein. J. Lipid Res. 13, 338-347 (1972).
2. Woeber, K. A. & Ingbar, S. H. The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J. Clin. Invest 47, 1710-1721 (1968).
3. Cornwell, G. G., III, Sletten, K., Johansson, B. & Westermark, P. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem. Biophys. Res. Commun. 154, 648-653 (1988).
4. Westermark, P., Sletten, K., Johansson, B. & Cornwell, G. G., III Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. U. S. A 87, 2843-2845 (1990).
5. Sousa, M. M., Cardoso, I., Fernandes, R., Guimarães, A. & Saraiva, M. J. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy. Am. J. Pathol. 159, 1993-2000 (2001).
6. Reixach, N., Deechongkit, S., Jiang, X., Kelly, J. W. & Buxbaum, J. N. Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc. Natl. Acad. Sci. U. S. A 101, 2817-2822 (2004).
7. Sorgjerd, K., Klingstedt, T., Lindgren, M., Kagedal, K. & Hammarstrom, P. Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture. Biochem. Biophys. Res. Commun. 377, 1072-1078 (2008).
8. Andersson, K., Olofsson, A., Nielsen, E. H., Svehag, S. E. & Lundgren, E. Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem. Biophys. Res. Commun. 294, 309-314 (2002).
9. Okamoto, S. et al. Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival. Liver Transpl. 15, 1229-1235 (2009).
10. Johnson, S. M., Connelly, S., Fearns, C., Powers, E. T. & Kelly, J. W. The transthyretin amyloidoses: From delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol. Biol 421, 185-203 (2012).
11. Hurshman, A. R., White, J. T., Powers, E. T. & Kelly, J. W. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43, 7365-7381 (2004).
12. Hammarstrom, P., Jiang, X., Hurshman, A. R., Powers, E. T. & Kelly, J. W. Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity. Proc. Natl. Acad. Sci. U. S. A 99 Suppl 4, 16427-16432 (2002).
13. Yang, M., Yordanov, B., Levy, Y., Bruschweiler, R. & Huo, S. The sequence-dependent unfolding pathway plays a critical role in the amyloidogenicity of transthyretin. Biochemistry 45, 11992-12002 (2006).
14. Jiang, X. et al. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 40, 11442-11452 (2001).
15. Inouye, H. et al. Analysis of x-ray diffraction patterns from amyloid of biopsied vitreous humor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: Axially arrayed TTR monomers constitute the protofilament. Amyloid 5, 163-174 (1998).
16. Nettleton, E. J. et al. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: Evidence from electrospray mass spectrometry. J Mol. Biol 281, 553-564 (1998).
17. Sorensen, J., Hamelberg, D., Schiott, B. & McCammon, J. A. Comparative MD analysis of the stability of transthyretin providing insight into the fibrillation mechanism. Biopolymers 86, 73-82 (2007).
18. Hamilton, J. A. & Benson, M. D. Transthyretin: A review from a structural perspective. Cell Mol. Life Sci. 58, 1491-1521 (2001).
19. Blake, C. & Serpell, L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous b-sheet helix. Structure 4, 989-998 (1996).
20. Hamilton, J. A. et al. The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-> Met variant to 1.7-A resolution. J Biol Chem 268, 2416-2424 (1993).
21. Foss, T. R., Wiseman, R. L. & Kelly, J. W. The pathway by which the tetrameric protein transthyretin dissociates. Biochemistry 44, 15525-15533 (2005).
22. Serag, A. A., Altenbach, C., Gingery, M., Hubbell, W. L. & Yeates, T. O. Identification of a subunit interface in transthyretin amyloid fibrils: Evidence for self-assembly from oligomeric building blocks. Biochemistry 40, 9089-9096 (2001).
23. Eneqvist, T., Andersson, K., Olofsson, A., Lundgren, E. & Sauer-Eriksson, A. E. The b-slip: A novel concept in transthyretin amyloidosis. Mol. Cell 6, 1207-1218 (2000).
24. Lindgren, M., Sörgjerd, K. & Hammarström, P. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. Biophys. J. 88, 4200-4212 (2005).
25. Lindgren, M. & Hammarstrom,P. Amyloid oligomers: Spectroscopic characterization of amyloidogenic protein states. FEBS J 277, 1380-1388 (2010).
26. Serag, A. A., Altenbach, C., Gingery, M., Hubbell, W. L. & Yeates, T. O. Arrangement of subunits and ordering of b-strands in an amyloid sheet. Nat. Struct. Biol. 9, 734-739 (2002).
27. Olofsson, A., Ippel, J. H., Wijmenga, S. S., Lundgren, E. & Ohman, A. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J. Biol. Chem. 279, 5699-5707 (2004).
28. Kodali, R. & Wetzel, R. Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. Struct. Biol 17, 48-57 (2007).
29. Serpell, L. C. et al. Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J. Mol. Biol. 254, 113-118 (1995).
30. Colon, W. & Kelly, J. W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31, 8654-8660 (1992).
31. McCutchen, S. L., Colon, W. & Kelly, J. W. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32, 12119-12127 (1993).
32. Groenning, M. et al. Thermodynamic stability and denaturation kinetics of a benign natural transthyretin mutant identified in a Danish kindred. Amyloid. 18, 35-46 (2011).
33. Pires, R. H., Saraiva, M. J., Damas, A. M. & Kellermayer, M. S. Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy. J Mol. Recognit. 24, 467-476 (2011).
34. Vestergaard, B. et al. A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biology 5, 1089-1097 (2007).
35. Giehm, L., Svergun, D. I., Otzen, D. E. & Vestergaard, B. Low-resolution structure of a vesicle disrupting a-synuclein oligomer that accumulates during fibrillation. Proc. Natl. Acad. Sci. U. S. A 108, 3246-3251 (2011).
36. Oliveira, C. L. et al. A SAXS study of glucagon fibrillation. J Mol. Biol 387, 147-161 (2009).
37. Mertens, H. D. & Svergun, D. I. Structural characterization of proteins and complexes using small-angle X-ray solution scattering. J Struct. Biol 172, 128-141 (2010).
38. Langkilde, A. E. & Vestergaard, B. Structural characterization of prefibrillar intermediates and amyloid fibrils by small-angle X-ray scattering. Methods Mol. Biol 849, 137-155 (2012).
39. DEBYE, P. Molecular-weight determination by light scattering. J Phys. Colloid Chem 51, 18-32 (1947).
40. Kozin, M. & Svergun, D. Automated matching of high-and low-resolution structural models. J. Appl. Cryst. 34, 33-41 (2000).
41. Jackson, M. & Mantsch, H. H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit Rev. Biochem. Mol. Biol 30, 95-120 (1995).
42. Cordeiro, Y. et al. Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin. Biophys. J 91, 957-967 (2006).
43. Zandomeneghi, G., Krebs, M. R. H., McCammon, M. G. & Fändrich, M. FTIR reveals structural differences between native b-sheet proteins and amyloid fibrils. Protein Sci. 13, 3314-3321 (2004).
44. Wang, L., Schubert, D., Sawaya, M. R., Eisenberg, D. & Riek, R. Multidimensional structure-activity relationship of a protein in its aggregated states. Angew. Chem Int. Ed Engl. 49, 3904-3908 (2010).
45. Barth, A. & Zscherp, C. What vibrations tell us about proteins. Q. Rev. Biophys. 35, 369-430 (2002).
46. Glenner, G. G., Eanes, E. D., Bladen, H. A., Linke, R. P. & Termine, J. D. Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem. Cytochem. 22, 1141-1158 (1974).
47. Cardoso, I. et al. Transthyretin fibrillogenesis entails the assembly of monomers: A molecular model for in vitro assembled transthyretin amyloid-like fibrils. J Mol. Biol 317, 683-695 (2002).
48. Maurer-Stroh, S. et al. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods 7, 237-242 (2010).
49. Bateman, D. A., Tycko, R. & Wickner, R. B. Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin. Biophys. J 101, 2485-2492 (2011).
50. Hou, X., Aguilar, M. I. & Small, D. H. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 274, 1637-1650 (2007).
51. Lai, Z., Colon, W. & Kelly, J. W. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35, 6470-6482 (1996).
52. Liu, K. et al. Deuterium-proton exchange on the native wild-type transthyretin tetramer identifies the stable core of the individual subunits and indicates mobility at the subunit interface. J. Mol. Biol. 303, 555-565 (2000).
53. Liu, K., Kelly, J. W. & Wemmer, D. E. Native state hydrogen exchange study of suppressor and pathogenic variants of transthyretin. J Mol. Biol 320, 821-832 (2002).
54. Liu, K., Cho, H. S., Lashuel, H. A., Kelly, J. W. & Wemmer, D. E. A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struct. Biol. 7, 754-757 (2000).
55. Pires, R. H., Karsai, A., Saraiva, M. J., Damas, A. M. & Kellermayer, M. S. Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils. PLoS One. 7, e44992 (2012).
56. Bonifacio, M. J., Sakaki, Y. & Saraiva, M. J. 'In vitro' amyloid fibril formation from transthyretin: The influence of ions and the amyloidogenicity of TTR variants. Biochim. Biophys. Acta 1316, 35-42 (1996).
57. Redondo, C., Damas, A. M. & Saraiva, M. J. Designing transthyretin mutants affecting tetrameric structure: Implications in amyloidogenicity. Biochem. J 348 Pt 1, 167-172 (2000).
58. Ferrone, F. Analysis of protein aggregation kinetics. Methods Enzymol. 309, 256-274 (1999).
59. Ihse, E. et al. Proportion between wild-type and mutant protein in truncated compared to full-length ATTR: An analysis on transplanted transthyretin T60A amyloidosis patients. Biochem. Biophys. Res. Commun. 379, 846-850 (2009).
60. Bergstrom, J. et al. Amyloid deposits in transthyretin-derived amyloidosis: Cleaved transthyretin is associated with distinct amyloid morphology. J Pathol. 206, 224-232 (2005).
61. Ihse, E. et al. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol. 216, 253-261 (2008).
62. Groenning, M. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J Chem Biol 3, 1-18 (2010).
63. Roessle, M. W. et al. Upgrade of the small-angle X-ray scattering beam line X33 at the European Molecular Biology Laboratory, Hamburg. J. Appl. Crystallogr. 40, 190-194 (2007).
64. Konarev, P. V., Petoukhov, M. V., Volkov, V. V. & Svergun, D. I. ATSAS 2.1, a program package for small-angle scattering data analysis. J. Appl. Crystallogr. 39, 277-286 (2006).
65. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J. & Svergun, D. I. PRIMUS: A Windows PC-based system for smallangle scattering data analysis. J. Appl. Crystallogr. 36, 1277-1282 (2003).
66. Svergun, D. I. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495-503 (1992).
67. Svergun, D. I., Barberato, C. & Koch, M. H. J. CRYSOL-a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Crystallogr. 28, 768-773 (1995).
68. Palaninathan, S. K., Mohamedmohaideen, N. N., Snee, W. C., Kelly, J. W. & Sacchettini, J. C. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer. J Mol. Biol 382, 1157-1167 (2008).
69. Svergun, D. I. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 76, 2879-2886 (1999).
70. Petoukhov, M. V. & Svergun, D. I. Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys. J. 89, 1237-1250 (2005).
71. Volkov, V. V. & Svergun, D. I. Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Crystallogr. 36, 860-864 (2003).
72. Petoukhov, M. V. et al. New developments in the ATSAS program package for small-angle scattering data analysis. J. Appl. Cryst. 45, 342-350 (2012).
73. Jorgensen, T. J., Gardsvoll, H., Dano, K., Roepstorff, P. & Ploug, M. Dynamics of urokinase receptor interaction with Peptide antagonists studied by amide hydrogen exchange and mass spectrometry. Biochemistry 43, 15044-15057 (2004).
74. Weis, D. D., Engen, J. R. & Kass, I. J. Semi-automated data processing of hydrogen exchange mass spectra using HX-Express. J Am. Soc. Mass Spectrom. 17, 1700-1703 (2006).
75. Perkins, D. N., Pappin, D. J., Creasy, D. M. & Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567 (1999).
76. Kabsch, W. & Sander, C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637 (1983).
77. Sreerama, N. & Woody, R. W. Estimation of protein secondary structure from circular dichroism spectra: Comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 287, 252-260 (2000).
78. Lobley, A., Whitmore, L. & Wallace, B. A. DICHROWEB: An interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics. 18, 211-212 (2002).
79. Whitmore, L. & Wallace, B. A. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 32, W668-W673 (2004).
80. Misumi, Y. et al. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication. Amyloid 15, 234-239 (2008).
81. Whitmore, L. & Wallace, B. A. Protein secondary structure analyses from circular dichroism spectroscopy: Methods and reference databases. Biopolymers 89, 392-400 (2008).
82. Stathopulos, P. B. et al. Sonication of proteins causes formation of aggregates that resemble amyloid. Protein Sci. 13, 3017-3027 (2004).